TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

You Are Here: Home  »  Research Funding  »  Funding Opportunities  » 

Skip secondary menu

NINDS Neuroscience Funding Announcements

RFI: Preclinical Development Facility for Medical Countermeasures Against Chemical Threats

Funding Contact(s): Helene Braun
Funding Categories: Translational Research

Brief Description:

The National Institute of Neurological Disorders and Stroke (NINDS) is considering issuing a contract for preclinical studies of new or improved pharmaceutical preparations to be used as medical countermeasures against chemical agents that could be used in a terrorist attack. As a first step, the Institute is attempting to identify expert sources to conduct safety, pharmacokinetic/biodistribution, and developmental chemistry studies with candidate drugs.

NIH Guide: NOT-NS-05-012
Release Date: 2005-09-02
Expiration Date: 2005-09-19